Ionix Technology, Inc. Announces Third Quarter 2020

New Post Public Reply Private Reply Replies (1) Message Board
Lee Adams
184
Ionix Technology, Inc. Announces Third Quarter 2020 Financial Results

LAS VEGAS, NV, May 18, 2020 (GLOBE NEWSWIRE) -- Ionix Technology, Inc. (OTCQB: IINX), ("Ionix Technology", "IINX" or "the Company", a business aggregator in photoelectric display and smart energy fields, announced its financial results for the three months ended March 31, 2020.

Third Quarter 2020 Financial Highlights:

Total revenues were $2,752,170 and $2,894,802 respectively for the three months ended March 31, 2020 and 2019.

Gross profit was $245,652 and $623,422, respectively for the three months ended March 31, 2020 and 2019.

During the three months ended March 31, 2020 and 2019 net income (loss) was $(636,222) and $21,064, respectively.
“From early February to the end of March, we closed all factories to limit the spread of COVID-19. The shutdown of business affected the operational and financial performance of IINX for the third quarter of 2020,” said Mr. Cheng Li, Chairman and CEO of Ionix Technology. “However, since restarting operations near the end of March, the Company’s financial performances have been recovering continuously as transportations returned to normal, all of the supply chains were restored and all of our factories resumed operations.”

Mr. Li continued, “While the near-term market environment will likely continue to be challenging, we believe we are well-positioned to navigate current conditions based on our continuous investment in research and development of industry-leading emerging technologies, our durable business model and our talented team. We will continue to operate at the highest efficiency and remain committed to working diligently on behalf of our investors.”

Revenue

During the three months ended March 31, 2020 and 2019, total revenues were $2,752,170 and $2,894,802, respectively. The total revenues decreased by $142,632 or 5% from the three months ended March 31, 2019 to the three months ended March 31, 2020.

During the three months ended March 31, 2020, COVID-19 affected the operational and financial performance of the Company as the PRC imposed a national economic shutdown to limit the spread of COVID-19 from early February to mid-March. At the same time the Company temporarily closed all of its factories while transportations in or out of them were suspended, and experienced an unprecedented “supplier chain break”. Since the restart of operations near the end of March, the Company’s financial performances have been recovering continuously as transportations have returned to normal, the supply chain wasrestored and all of its factories resumed working.

During the nine months ended March 31, 2020 and 2019, total revenues were $17,585,468 and $7,841,437, respectively. The total revenues increased by $9,744,031 or 124% from the nine months ended March 31, 2019 to the nine months ended March 31, 2020.

Among the significant increase of $9,744,031 in total revenues for the nine months ended March 31, 2020, $11,581,460 was the revenue from Fangguan Electronics which was acquired on December 27, 2018. The acquisition expanded the Company’s operations in the fields of LCM in the PRC and significantly increased the volume of goods (LCD, etc.) being sold.

The increase in total revenues due to acquisition of Fangguan Electronics was partially offset by the decreases of $1,837,429 related to the other business (excluding Fangguan Electronics) for the nine months ended March 31, 2020 compared to 2019. After Fangguan Electronics was acquired, all business of Fangguan Photoelectric was replaced by Fangguan Electronics, which caused total revenues to decrease by $2,407,535 respectively for the nine months ended March 31, 2020.

Cost of Revenue

During the three months ended March 31, 2020 and 2019, the total cost of revenues was $2,506,518 and $2,271,380, respectively. The total cost of revenues increased by $235,138 or 10% from the three months ended March 31, 2019 to the three months ended March 31, 2020.

During the nine months ended March 31, 2020 and 2019, the total cost of revenues was $14,850,194 and $6,618,015 respectively. The total cost of revenues increased by $8,232,179 or 124% from the nine months ended March 31, 2019 to the nine months ended March 31, 2020.

Among the significant increase of $8,232,179 in total cost of revenues for the nine months ended March 31, 2020 compared to 2019, the $9,991,514 increase can be directly attributed to the acquisition of Fangguan Electronics on December 27, 2018.

The increase in total cost of revenues due to acquisition of Fangguan Electronics was partially offset by the decreases of $1,759,335 related to the other business (excluding Fangguan Electronics) for the nine months ended March 31, 2020 compared to 2019. After Fangguan Electronics was acquired, all business of Fangguan Photoelectric was replaced by Fangguan Electronics, which caused total cost of revenues to decrease by $2,076,990 for the nine months ended March 31, 2020.

Gross Profit

During the three months ended March 31, 2020 and 2019, the gross profit was $245,652 and $623,422, respectively. Gross profit margin was at 9% during the three months ended March 31, 2020 as compared to 22% for the three months ended March 31, 2019.

The decrease in both gross profit and gross profit margin can be attributed to the fact that starting from second fiscal quarter, the Company adopted the new business strategy to have low gross profits and increase sales volume.

Selling, General and Administrative Expenses

During the three months ended March 31, 2020 and 2019, selling, general and administrative expenses were $499,616 and $392,367, respectively.

The difference can be attributed to the depreciation and amortization expenses, payroll expenses, professional fees and other expenses incurred during the three months ended March 31, 2020 after Fangguan Electronics became a variable interest entity of the Company on December 27, 2018.

Research and Development Expenses

During the three months ended March 31, 2020 and 2019, research and development expenses were $139,029 and $158,562, respectively.

Net Income (Loss)

During the three months ended March 31, 2020 and 2019 net income (loss) was $(636,222) and $21,064, respectively.

The change can be attributed to the decrease in gross profits and the increase of expenses during the three months ended March 31, 2020.

Cash and Financial Position

As of March 31, 2020, the Company had cash and cash equivalents of $1,834,763, compared to $509,615 as of June 30, 2019.

The Company had a working capital of $1,828,672 as of March 31, 2020 compared to working capital of $717,977 as of June 30, 2019.

During the nine months ended March 31, 2020, net cash provided by operating activities was $641,370 compared to net cash used in operating activities of $900,588 for the nine months ended March 31, 2019. The change was mainly due to the increase of $5,641 in the net income, an increase of $766,310 resulting from adjustments to net income for non-cash items, and a decrease of $770,007 in cash outflow from changes in operating assets and liabilities in the nine months ended March 31, 2020 compared to same period in 2019.

During the nine months ended March 31, 2020, net cash used in investing activities was $71,895 compared to net cash provided by investing activities of $649,216 for the nine months ended March 31, 2019. Cash used in the acquisition of the equipment increased by $155,235 in the nine months ended March 31, 2020 compared to same period in 2019 due to acquisition of Fangguan Electronics. In addition, the Company also received cash of $687,591 in December 2018 due to the acquisition of Fangguan Electronics.

During the nine months ended March 31, 2020, cash provided by financing activities was $787,503, which was primarily due to the proceeds received from issuance of convertible notes. During the nine months ended March 31, 2019, the Company received $588,062 in cash for financing activities, which was primarily attributable to the proceeds from the related party loans offsetting by the return of capital to non-controlling interests.

About Ionix Technology, Inc.

Ionix Technology, Inc. is a holding company that is principally engaged in the photoelectric display and smart energy industries. The company has five operating subsidiaries: Changchun Fangguan Electronics Technology Co., Ltd, a company which has been focusing on R&D, manufacturing and marketing LCM and LCD. Changchun Fangguan Photoelectric Display Technology Co., Ltd, a company which specializes in developing, designing, and selling TN and STN LCD, STN, CSTN, and TFT LCD modules as well as other related products; Shenzhen Baileqi Electronic Technology Co., Ltd, a company which specializes in LCD slicing, filling, researching and designing, and selling of LCD Modules (LCM) and PCBs; Lisite Science Technology (Shenzhen) Co., Ltd., a company engaged in the marketing and selling of intelligent electronic devices; and Dalian Shizhe New Energy Technology Co., Ltd., a company engaged in the new energy support service, and operating the photovoltaic power generation, electric vehicles and charging piles with corresponding operation and maintenance and three dimensional parking. Currently, IINX has embarked on the layout of industrialization and marketization of front end materials and back end modules of liquid crystal displays and applications of flexible folding display technology by taking Fangguan Electronics as production bases, to seize the market share of OLED high technology.

To learn more, please visit our website: www.theiinx.com

Safe Harbor Statement

This news release contains "forward-looking statements" as that term is defined in the United States Securities Act of 1933, as amended and the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements, including beliefs, plans, expectations or intentions regarding the future, and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors, such as the inherent uncertainties associated with new business opportunities and development stage companies. Ionix Technology assumes no obligation to update the forward-looking statements. Although Ionix Technology believes that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that they will prove to be accurate. Investors should refer to the risk factors disclosure outlined in Ionix Technology's annual report on Form 10-K for the most recent fiscal year, quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the U.S. Securities and Exchange Commission.

IR Contact:

Dragon Gate Investment Partners LLC

Tel: +1(646)-801-2803

Email: iinx@dgipl.com



(financial tables follow; please see 10-Q filed with SEC May 15, 2020 for notes to financial statements which are an integral part of the financial statements)

IONIX TECHNOLOGY, INC.
CONSOLIDATED BALANCE SHEETS
(Unaudited)

March 31, 2020 June 30, 2019
ASSETS
Current Assets:
Cash and cash equivalents (Note 3 at VIE) $ 1,834,763 $ 509,615
Notes receivable (Note 3 at VIE) 23,721 120,182
Accounts receivable - non-related parties (Note 3 at VIE) 3,494,207 3,639,030
- related parties 420,906 340,026
Inventory (Note 3 at VIE) 3,045,127 3,379,146
Advances to suppliers - non-related parties (Note 3 at VIE) 354,820 129,423
- related parties 264,797 269,498
Prepaid expenses and other current assets (Note 3 at VIE) 593,122 269,495
Total Current Assets (Note 3 at VIE) 10,031,463 8,656,415

Property, plant and equipment, net (Note 3 at VIE) 6,812,910 7,508,637
Right-of-use assets – operating leases 20,825 -
Intangible assets, net (Note 3 at VIE) 1,430,449 1,496,399
Deferred tax assets (Note 3 at VIE) 51,460 54,361
Total Assets (Note 3 at VIE) $ 18,347,107 $ 17,715,812

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Short-term bank loan (Note 3 at VIE) $ 2,540,543 $ 2,618,296
Accounts payable (Note 3 at VIE) 2,569,420 2,732,327
Advance from customers (Note 3 at VIE) 59,165 114,158
Convertible notes payable, net of debt discount and loan cost 347,427 -
Derivative liability 446,852 -
Due to related parties (Note 3 at VIE) 2,032,723 2,105,338
Operating lease liabilities – current portion 7,646 -
Accrued expenses and other current liabilities (Note 3 at VIE) 199,015 368,319
Total Current Liabilities (Note 3 at VIE) 8,202,791 7,938,438

Operating lease liabilities 12,462 -
Total Liabilities (Note 3 at VIE) 8,215,253 7,938,438

COMMITMENT AND CONTINGENCIES

Stockholders’ Equity:
Preferred stock, $.0001 par value, 5,000,000 shares authorized,
5,000,000 shares issued and outstanding 500 500
Common stock, $.0001 par value, 195,000,000 shares
authorized, 114,193,057 and 114,003,000 shares issued and
outstanding as of March 31, 2020 and June 30, 2019,
respectively 11,419 11,400
Additional paid in capital 9,299,825 8,829,487
Retained earnings 750,578 539,866
Accumulated other comprehensive loss (372,429 ) (45,840 )
Total Stockholders' Equity attributable to the Company 9,689,893 9,335,413
Noncontrolling interest 441,961 441,961
Total Stockholders’ Equity 10,131,854 9,777,374
Total Liabilities and Stockholders’ Equity $ 18,347,107 $ 17,715,812
IONIX TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited)

For the Three Months Ended For the Nine Months Ended
March 31, March 31,
2020 2019 2020 2019

Revenues (See Note 2 and Note 9 for
related party amounts) $ 2,752,170 $ 2,894,802 $ 17,585,468 $ 7,841,437

Cost of Revenues (See Note 9 for related
party amounts) 2,506,518 2,271,380 14,850,194 6,618,015

Gross profit 245,652 623,422 2,735,274 1,223,422

Operating expenses
Selling, general and administrative expense 499,616 392,367 1,378,241 686,132
Research and development expense 139,029 158,562 645,880 158,562
Total operating expenses 638,645 550,929 2,024,121 844,694

Income (loss) from operations (392,993 ) 72,493 711,153 378,728

Other income (expense):
Interest expense, net of interest income (213,267 ) (34,412 ) (470,500 ) (34,412 )
Subsidy income - - 50,018 -
Change in fair value of derivative liability (44,850 ) - 86,602 -
Loss on extinguishment of debt (15,074 ) - (15,074 ) -
Total other expense (273,191 ) (34,412 ) (348,954 ) (34,412 )

Income (loss) before income tax provision (666,184 ) 38,081 362,199 344,316

Income tax provision (benefit) (29,962 ) 17,017 151,487 139,245
Net income (loss) (636,222 ) 21,064 210,712 205,071

Other comprehensive income (loss)
Foreign currency translation adjustment (165,507 ) 56,484 (326,589 ) 28,523
Comprehensive income (loss) $ (801,729 ) $ 77,548 $ (115,877 ) $ 233,594


Earnings (Loss) Per Share - Basic $ (0.01 ) $ 0.00 $ 0.00 $ 0.00
Weighted average number of common
shares outstanding - Basic 114,104,735 114,003,000 114,036,665 104,148,985

Earnings (Loss) Per Share - Diluted $ (0.01 ) $ 0.00 $ 0.00 $ 0.00
Weighted average number of common
shares outstanding - Diluted 113,913,240 114,003,000 114,036,665 104,148,985

IONIX TECHNOLOGY, INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)

For the Nine Months Ended
March 31,
2020 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net income $ 210,712 $ 205,071
Adjustments required to reconcile net income to net cash provided by
(used in) operating activities:
Depreciation and amortization 580,625 184,172
Deferred taxes 1,306 (15,732 )
Stock compensation for advisory services 79,891 -
Change in fair value of derivative liability (86,602 ) -
Loss on extinguishment of debt 15,074 -
Non-cash interest 351,474 -
Gain on disposal of property and equipment (7,018 ) -
Changes in operating assets and liabilities:
Accounts receivable - non-related parties 37,312 593,935
Accounts receivable - related parties (92,348 ) (22,607 )
Inventory 237,193 (774,776 )
Advances to suppliers - non-related parties (232,695 ) 13,826
Advances to suppliers - related parties (3,352 ) (114,802 )
Prepaid expenses and other current assets (150,496 ) (75,559 )
Accounts payable - non-related parties (83,000 ) (645,258 )
Accounts payable - related parties - (198,782 )
Advance from customers (52,380 ) (61,014 )
Accrued expenses and other current liabilities (164,326 ) 10,938
Net cash provided by (used in) operating activities 641,370 (900,588 )

CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of property, plant and equipment (193,610 ) (38,375 )
Proceeds received from sale of equipment 121,715 -
Cash received from acquisition - 687,591
Net cash provided by (used in) investing activities (71,895 ) 649,216

CASH FLOWS FROM FINANCING ACTIVITIES
Notes receivable 94,292 54,451
Proceeds from issuance of convertible notes payable 722,190 -
Return of capital to non-controlling interests - (58,155 )
Proceeds from (repayment of) loans from related parties (28,979 ) 591,766
Net cash provided by financing activities 787,503 588,062

Effect of exchange rate changes on cash (31,830 ) 46,668

Net increase in cash and cash equivalents 1,325,148 383,358

Cash and cash equivalents, beginning of period 509,615 111,462

Cash and cash equivalents, end of period $ 1,834,763 $ 494,820

Supplemental disclosure of cash flow information
Cash paid for income tax $ 154,538 $ 144,124
Cash paid for interests $ 102,457 $ 35,250

Non-cash investing and financing activities
Issuance of 15,000,000 shares of common stock in exchange for
95.14% ownership rights of a variable interest entity $ - $ 8,651,896
Issuance of common stock for advisory services $ 262,500 $ -
Issuance of 40,057 shares of common stock for conversion of
convertible notes $ 60,365 $ -
The accompanying notes are an integral part of these consolidated financial statements.

Ionix Technology, Inc. (IINX) Stock Research Links

IINX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 15

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 55

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 513

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 236

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 45

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 308

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Applied Materials: Navigating Earnings Signals and Market Trends

Updated Category News Views 180

Applied Materials: What's Ahead for Investors? Applied Materials Inc has emerged as one of the most prominent performers in the stock market lately. With shares showing an impressive increase of 26% year-to-date and an astounding 170% rise since the previous spring, investors are buzzing about its success and future. This surge has garnered attention, especially as the...

Continue Reading
Transforming Money for the Digital Age with Lightspark

Updated Category News Views 363

Reimagining Financial Transactions with Lightspark Lightspark launched with a vision to revolutionize the way we perceive and use money, aiming to cultivate a future where financial interactions mirror the rapid connectivity of the internet. With the burgeoning demand for swift, borderless, and seamless value transfer, it's imperative that financial infrastructures evolve...

Continue Reading
XploraDEX Token Launch Sets New Stage for DeFi Innovation

Updated Category News Views 184

Exciting News from XploraDEX's Ecosystem In a remarkable development, the XploraDEX ecosystem has officially initiated the distribution of the highly anticipated $XPL Token. This signifies a pivotal transition from the fundraising phase to a more active operational state. As part of the early rollout, initial investors are beginning to receive their tokens, marking a...

Continue Reading
Empire Development Unveils Luxurious Real Estate Offerings

Updated Category News Views 253

Empire Development Unveils Gorgeous New Properties Empire Development is excited to share the addition of three stunning properties to its luxury real estate collection. These remarkable homes, exclusively listed by the Senada Adzem Team of Douglas Elliman Real Estate, reflect the company’s dedication to redefining luxury in today’s market. Discovering Outstanding...

Continue Reading
Biden's Final Moves: Key Actions Before Transitioning Power

Updated Category News Views 169

Biden's Urgent Priorities Before the Transition As President Joe Biden approaches the end of his term, he faces an extensive list of foreign and domestic challenges he aims to address. With the impending transition to president-elect Donald Trump, whose administration is anticipated to overturn much of Biden's work, the urgency to act has increased significantly. Foreign...

Continue Reading